Suppl. Fig. 4 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment Article Swipe
Luo Ren
,
Elke Firat
,
Simone Gaedicke
,
Elena Guffart
,
Tsubasa Watanabe
,
Gabriele Niedermann
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22471538
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/1078-0432.22471538
Ratio of tumor-specific CD8+ T cells to tumor cells is enhanced upon treatment with cisplatin + anti-PD-1.
Related Topics
Concepts
Blockade
CXCR3
Cisplatin
CD8
Immune checkpoint
Cytotoxic T cell
Cancer research
CXCL10
Chemistry
Abscopal effect
PD-L1
Cell biology
Medicine
Biology
Immunotherapy
Immune system
Immunology
Internal medicine
Chemokine
Chemotherapy
Biochemistry
Receptor
In vitro
Chemokine receptor
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/1078-0432.22471538
- https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_4_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471538/1/files/39923021.pdf
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361969707
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361969707Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/1078-0432.22471538Digital Object Identifier
- Title
-
Suppl. Fig. 4 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell RecruitmentWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Luo Ren, Elke Firat, Simone Gaedicke, Elena Guffart, Tsubasa Watanabe, Gabriele NiedermannList of authors in order
- Landing page
-
https://doi.org/10.1158/1078-0432.22471538Publisher landing page
- PDF URL
-
https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_4_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471538/1/files/39923021.pdfDirect link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_4_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471538/1/files/39923021.pdfDirect OA link when available
- Concepts
-
Blockade, CXCR3, Cisplatin, CD8, Immune checkpoint, Cytotoxic T cell, Cancer research, CXCL10, Chemistry, Abscopal effect, PD-L1, Cell biology, Medicine, Biology, Immunotherapy, Immune system, Immunology, Internal medicine, Chemokine, Chemotherapy, Biochemistry, Receptor, In vitro, Chemokine receptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361969707 |
|---|---|
| doi | https://doi.org/10.1158/1078-0432.22471538 |
| ids.doi | https://doi.org/10.1158/1078-0432.22471538 |
| ids.openalex | https://openalex.org/W4361969707 |
| fwci | |
| type | preprint |
| title | Suppl. Fig. 4 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10158 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9955999851226807 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Cancer Immunotherapy and Biomarkers |
| topics[1].id | https://openalex.org/T10782 |
| topics[1].field.id | https://openalex.org/fields/22 |
| topics[1].field.display_name | Engineering |
| topics[1].score | 0.9700000286102295 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2204 |
| topics[1].subfield.display_name | Biomedical Engineering |
| topics[1].display_name | Nanoplatforms for cancer theranostics |
| topics[2].id | https://openalex.org/T12064 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.968999981880188 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2746 |
| topics[2].subfield.display_name | Surgery |
| topics[2].display_name | Intraperitoneal and Appendiceal Malignancies |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2778468042 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7868697047233582 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q273976 |
| concepts[0].display_name | Blockade |
| concepts[1].id | https://openalex.org/C25532541 |
| concepts[1].level | 5 |
| concepts[1].score | 0.7128722667694092 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q655541 |
| concepts[1].display_name | CXCR3 |
| concepts[2].id | https://openalex.org/C2778239845 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6906935572624207 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q412415 |
| concepts[2].display_name | Cisplatin |
| concepts[3].id | https://openalex.org/C167672396 |
| concepts[3].level | 3 |
| concepts[3].score | 0.5943569540977478 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q417800 |
| concepts[3].display_name | CD8 |
| concepts[4].id | https://openalex.org/C2780851360 |
| concepts[4].level | 4 |
| concepts[4].score | 0.572115421295166 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q21686041 |
| concepts[4].display_name | Immune checkpoint |
| concepts[5].id | https://openalex.org/C154317977 |
| concepts[5].level | 3 |
| concepts[5].score | 0.5294100046157837 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q376266 |
| concepts[5].display_name | Cytotoxic T cell |
| concepts[6].id | https://openalex.org/C502942594 |
| concepts[6].level | 1 |
| concepts[6].score | 0.5048490166664124 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[6].display_name | Cancer research |
| concepts[7].id | https://openalex.org/C5858377 |
| concepts[7].level | 4 |
| concepts[7].score | 0.48466283082962036 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q986112 |
| concepts[7].display_name | CXCL10 |
| concepts[8].id | https://openalex.org/C185592680 |
| concepts[8].level | 0 |
| concepts[8].score | 0.483478844165802 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[8].display_name | Chemistry |
| concepts[9].id | https://openalex.org/C2781274730 |
| concepts[9].level | 4 |
| concepts[9].score | 0.4705484211444855 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q4669679 |
| concepts[9].display_name | Abscopal effect |
| concepts[10].id | https://openalex.org/C2781053074 |
| concepts[10].level | 4 |
| concepts[10].score | 0.4599892199039459 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q21100639 |
| concepts[10].display_name | PD-L1 |
| concepts[11].id | https://openalex.org/C95444343 |
| concepts[11].level | 1 |
| concepts[11].score | 0.32181477546691895 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[11].display_name | Cell biology |
| concepts[12].id | https://openalex.org/C71924100 |
| concepts[12].level | 0 |
| concepts[12].score | 0.2903088331222534 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[12].display_name | Medicine |
| concepts[13].id | https://openalex.org/C86803240 |
| concepts[13].level | 0 |
| concepts[13].score | 0.2867618501186371 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[13].display_name | Biology |
| concepts[14].id | https://openalex.org/C2777701055 |
| concepts[14].level | 3 |
| concepts[14].score | 0.25497370958328247 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[14].display_name | Immunotherapy |
| concepts[15].id | https://openalex.org/C8891405 |
| concepts[15].level | 2 |
| concepts[15].score | 0.25024211406707764 |
| concepts[15].wikidata | https://www.wikidata.org/wiki/Q1059 |
| concepts[15].display_name | Immune system |
| concepts[16].id | https://openalex.org/C203014093 |
| concepts[16].level | 1 |
| concepts[16].score | 0.24684011936187744 |
| concepts[16].wikidata | https://www.wikidata.org/wiki/Q101929 |
| concepts[16].display_name | Immunology |
| concepts[17].id | https://openalex.org/C126322002 |
| concepts[17].level | 1 |
| concepts[17].score | 0.2093716263771057 |
| concepts[17].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[17].display_name | Internal medicine |
| concepts[18].id | https://openalex.org/C13373296 |
| concepts[18].level | 3 |
| concepts[18].score | 0.14124220609664917 |
| concepts[18].wikidata | https://www.wikidata.org/wiki/Q421866 |
| concepts[18].display_name | Chemokine |
| concepts[19].id | https://openalex.org/C2776694085 |
| concepts[19].level | 2 |
| concepts[19].score | 0.11718225479125977 |
| concepts[19].wikidata | https://www.wikidata.org/wiki/Q974135 |
| concepts[19].display_name | Chemotherapy |
| concepts[20].id | https://openalex.org/C55493867 |
| concepts[20].level | 1 |
| concepts[20].score | 0.11491122841835022 |
| concepts[20].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[20].display_name | Biochemistry |
| concepts[21].id | https://openalex.org/C170493617 |
| concepts[21].level | 2 |
| concepts[21].score | 0.09156849980354309 |
| concepts[21].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[21].display_name | Receptor |
| concepts[22].id | https://openalex.org/C202751555 |
| concepts[22].level | 2 |
| concepts[22].score | 0.07148832082748413 |
| concepts[22].wikidata | https://www.wikidata.org/wiki/Q221681 |
| concepts[22].display_name | In vitro |
| concepts[23].id | https://openalex.org/C12823836 |
| concepts[23].level | 4 |
| concepts[23].score | 0.0 |
| concepts[23].wikidata | https://www.wikidata.org/wiki/Q24720618 |
| concepts[23].display_name | Chemokine receptor |
| keywords[0].id | https://openalex.org/keywords/blockade |
| keywords[0].score | 0.7868697047233582 |
| keywords[0].display_name | Blockade |
| keywords[1].id | https://openalex.org/keywords/cxcr3 |
| keywords[1].score | 0.7128722667694092 |
| keywords[1].display_name | CXCR3 |
| keywords[2].id | https://openalex.org/keywords/cisplatin |
| keywords[2].score | 0.6906935572624207 |
| keywords[2].display_name | Cisplatin |
| keywords[3].id | https://openalex.org/keywords/cd8 |
| keywords[3].score | 0.5943569540977478 |
| keywords[3].display_name | CD8 |
| keywords[4].id | https://openalex.org/keywords/immune-checkpoint |
| keywords[4].score | 0.572115421295166 |
| keywords[4].display_name | Immune checkpoint |
| keywords[5].id | https://openalex.org/keywords/cytotoxic-t-cell |
| keywords[5].score | 0.5294100046157837 |
| keywords[5].display_name | Cytotoxic T cell |
| keywords[6].id | https://openalex.org/keywords/cancer-research |
| keywords[6].score | 0.5048490166664124 |
| keywords[6].display_name | Cancer research |
| keywords[7].id | https://openalex.org/keywords/cxcl10 |
| keywords[7].score | 0.48466283082962036 |
| keywords[7].display_name | CXCL10 |
| keywords[8].id | https://openalex.org/keywords/chemistry |
| keywords[8].score | 0.483478844165802 |
| keywords[8].display_name | Chemistry |
| keywords[9].id | https://openalex.org/keywords/abscopal-effect |
| keywords[9].score | 0.4705484211444855 |
| keywords[9].display_name | Abscopal effect |
| keywords[10].id | https://openalex.org/keywords/pd-l1 |
| keywords[10].score | 0.4599892199039459 |
| keywords[10].display_name | PD-L1 |
| keywords[11].id | https://openalex.org/keywords/cell-biology |
| keywords[11].score | 0.32181477546691895 |
| keywords[11].display_name | Cell biology |
| keywords[12].id | https://openalex.org/keywords/medicine |
| keywords[12].score | 0.2903088331222534 |
| keywords[12].display_name | Medicine |
| keywords[13].id | https://openalex.org/keywords/biology |
| keywords[13].score | 0.2867618501186371 |
| keywords[13].display_name | Biology |
| keywords[14].id | https://openalex.org/keywords/immunotherapy |
| keywords[14].score | 0.25497370958328247 |
| keywords[14].display_name | Immunotherapy |
| keywords[15].id | https://openalex.org/keywords/immune-system |
| keywords[15].score | 0.25024211406707764 |
| keywords[15].display_name | Immune system |
| keywords[16].id | https://openalex.org/keywords/immunology |
| keywords[16].score | 0.24684011936187744 |
| keywords[16].display_name | Immunology |
| keywords[17].id | https://openalex.org/keywords/internal-medicine |
| keywords[17].score | 0.2093716263771057 |
| keywords[17].display_name | Internal medicine |
| keywords[18].id | https://openalex.org/keywords/chemokine |
| keywords[18].score | 0.14124220609664917 |
| keywords[18].display_name | Chemokine |
| keywords[19].id | https://openalex.org/keywords/chemotherapy |
| keywords[19].score | 0.11718225479125977 |
| keywords[19].display_name | Chemotherapy |
| keywords[20].id | https://openalex.org/keywords/biochemistry |
| keywords[20].score | 0.11491122841835022 |
| keywords[20].display_name | Biochemistry |
| keywords[21].id | https://openalex.org/keywords/receptor |
| keywords[21].score | 0.09156849980354309 |
| keywords[21].display_name | Receptor |
| keywords[22].id | https://openalex.org/keywords/in-vitro |
| keywords[22].score | 0.07148832082748413 |
| keywords[22].display_name | In vitro |
| language | en |
| locations[0].id | doi:10.1158/1078-0432.22471538 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_4_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471538/1/files/39923021.pdf |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/1078-0432.22471538 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5027929564 |
| authorships[0].author.orcid | https://orcid.org/0000-0001-9508-5497 |
| authorships[0].author.display_name | Luo Ren |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Ren Luo |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5086398080 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5959-4523 |
| authorships[1].author.display_name | Elke Firat |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Elke Firat |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5077293409 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7496-4994 |
| authorships[2].author.display_name | Simone Gaedicke |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Simone Gaedicke |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5084350302 |
| authorships[3].author.orcid | https://orcid.org/0000-0002-7691-8411 |
| authorships[3].author.display_name | Elena Guffart |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Elena Guffart |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5102268946 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Tsubasa Watanabe |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Tsubasa Watanabe |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5081477925 |
| authorships[5].author.orcid | https://orcid.org/0000-0003-1710-0975 |
| authorships[5].author.display_name | Gabriele Niedermann |
| authorships[5].author_position | last |
| authorships[5].raw_author_name | Gabriele Niedermann |
| authorships[5].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_4_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471538/1/files/39923021.pdf |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Suppl. Fig. 4 from Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10158 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9955999851226807 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Cancer Immunotherapy and Biomarkers |
| related_works | https://openalex.org/W2901738685, https://openalex.org/W2112744681, https://openalex.org/W2485523530, https://openalex.org/W2793584160, https://openalex.org/W2086427126, https://openalex.org/W1997773579, https://openalex.org/W2361685396, https://openalex.org/W2050659130, https://openalex.org/W2375240537, https://openalex.org/W2350279506 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/1078-0432.22471538 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_4_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471538/1/files/39923021.pdf |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/1078-0432.22471538 |
| primary_location.id | doi:10.1158/1078-0432.22471538 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://aacr.figshare.com/articles/journal_contribution/Suppl_Fig_4_from_Cisplatin_Facilitates_Radiation-Induced_Abscopal_Effects_in_Conjunction_with_PD-1_Checkpoint_Blockade_Through_CXCR3_CXCL10-Mediated_T-cell_Recruitment/22471538/1/files/39923021.pdf |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/1078-0432.22471538 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.+ | 15 |
| abstract_inverted_index.T | 4 |
| abstract_inverted_index.is | 9 |
| abstract_inverted_index.of | 1 |
| abstract_inverted_index.to | 6 |
| abstract_inverted_index.CD8+ | 3 |
| abstract_inverted_index.upon | 11 |
| abstract_inverted_index.with | 13 |
| abstract_inverted_index.cells | 5, 8 |
| abstract_inverted_index.tumor | 7 |
| abstract_inverted_index.enhanced | 10 |
| abstract_inverted_index.cisplatin | 14 |
| abstract_inverted_index.treatment | 12 |
| abstract_inverted_index.<p>Ratio | 0 |
| abstract_inverted_index.tumor-specific | 2 |
| abstract_inverted_index.anti-PD-1.</p> | 16 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 6 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.5799999833106995 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.19718631 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |